Literature DB >> 21506619

The economics of the NHS cancer drugs fund.

Alan Maynard1, Karen Bloor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21506619     DOI： 10.2165/11585750-000000000-00000

Source DB:  PubMed          Journal:  Appl Health Econ Health Policy        ISSN： 1175-5652            Impact factor:   2.561


× No keyword cloud information.
  3 in total

1.  The importance of being NICE.

Authors:  Annette Rid; Peter Littlejohns; James Wilson; Benedict Rumbold; Katharina Kieslich; Albert Weale
Journal:  J R Soc Med       Date:  2015-10-02       Impact factor: 5.344

Review 2.  Market access of cancer drugs in European countries: improving resource allocation.

Authors:  Kim Pauwels; Isabelle Huys; Minne Casteels; Katelijne De Nys; Steven Simoens
Journal:  Target Oncol       Date:  2013-11-19       Impact factor: 4.493

3.  The Relevance of Including Future Healthcare Costs in Cost-Effectiveness Threshold Calculations for the UK NHS.

Authors:  Megan Perry-Duxbury; James Lomas; Miqdad Asaria; Pieter van Baal
Journal:  Pharmacoeconomics       Date:  2021-10-26       Impact factor: 4.981
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.